These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38714521)

  • 21. eIF5B regulates the expression of PD-L1 in prostate cancer cells by interacting with Wig1.
    Li Q; Xiao M; Shi Y; Hu J; Bi T; Wang C; Yan L; Li X
    BMC Cancer; 2021 Sep; 21(1):1022. PubMed ID: 34525951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune Profile Analysis in Peripheral Blood and Tumor in Patients with Malignant Melanoma.
    Saito R; Sawada Y; Nakamura M
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. siRNA knockdown of PD-L1 and PD-L2 in monocyte-derived dendritic cells only modestly improves proliferative responses to Gag by CD8(+) T cells from HIV-1-infected individuals.
    Breton G; Yassine-Diab B; Cohn L; Boulassel MR; Routy JP; Sékaly RP; Steinman RM
    J Clin Immunol; 2009 Sep; 29(5):637-45. PubMed ID: 19562472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of potent cytotoxic T lymphocytes against castration-resistant prostate cancer cells by dendritic cells loaded with dying allogeneic prostate cancer cells.
    Hwang EC; Lim MS; Im CM; Kwon DD; Lee HJ; Nguyen-Pham TN; Lee YK; Lee JJ
    Scand J Immunol; 2013 Feb; 77(2):117-24. PubMed ID: 23126536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of programmed death ligand 1 in dendritic cells inhibits allogeneic lymphocyte activation in mice.
    Li W; Wang X; Chen R; Zhu H; Chen G; Sun X
    J Surg Res; 2012 Aug; 176(2):e79-87. PubMed ID: 22381170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monophosphoryl lipid A-induced activation of plasmacytoid dendritic cells enhances the anti-cancer effects of anti-PD-L1 antibodies.
    Zhang W; Lim SM; Hwang J; Ramalingam S; Kim M; Jin JO
    Cancer Immunol Immunother; 2021 Mar; 70(3):689-700. PubMed ID: 32902663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A combination of check-point blockade and α-galactosylceramide elicits long-lasting suppressive effects on murine hepatoma cell growth in vivo.
    Ishii K; Shimizu M; Kogo H; Negishi Y; Tamura H; Morita R; Takahashi H
    Immunobiology; 2020 Jan; 225(1):151860. PubMed ID: 31812347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Wnt Inhibition Sensitizes PD-L1 Blockade Therapy by Overcoming Bone Marrow-Derived Myofibroblasts-Mediated Immune Resistance in Tumors.
    Huang T; Li F; Cheng X; Wang J; Zhang W; Zhang B; Tang Y; Li Q; Zhou C; Tu S
    Front Immunol; 2021; 12():619209. PubMed ID: 33790893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sunitinib Exerts
    Ocadlikova D; Lecciso M; Broto JM; Scotlandi K; Cavo M; Curti A; Palmerini E
    Front Immunol; 2021; 12():577766. PubMed ID: 33717062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liposome Nanomedicine Based on Tumor Cell Lysate Mitigates the Progression of Lynch Syndrome-Associated Colon Cancer.
    Wang P; Zhong W; Huang Q; Zhu Y; Chen L; Ye K
    ACS Biomater Sci Eng; 2024 May; 10(5):3136-3147. PubMed ID: 38663028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model.
    Yu P; Steel JC; Zhang M; Morris JC; Waitz R; Fasso M; Allison JP; Waldmann TA
    Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6187-92. PubMed ID: 22474386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Programmed Death Ligand 1-Expressing Classical Dendritic Cells MitigateHelicobacter-Induced Gastritis.
    Go DM; Lee SH; Lee SH; Woo SH; Kim K; Kim K; Park KS; Park JH; Ha SJ; Kim WH; Choi JH; Kim DY
    Cell Mol Gastroenterol Hepatol; 2021; 12(2):715-739. PubMed ID: 33894424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of programmed death 1 ligands by murine T cells and APC.
    Yamazaki T; Akiba H; Iwai H; Matsuda H; Aoki M; Tanno Y; Shin T; Tsuchiya H; Pardoll DM; Okumura K; Azuma M; Yagita H
    J Immunol; 2002 Nov; 169(10):5538-45. PubMed ID: 12421930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 35. Fine-tuned expression of programmed death 1 ligands in mature dendritic cells stimulated by CD40 ligand is critical for the induction of an efficient tumor specific immune response.
    Gu T; Zhu YB; Chen C; Li M; Chen YJ; Yu GH; Ge Y; Zhou SY; Zhou H; Huang Y; Qiu YH; Zhang XG
    Cell Mol Immunol; 2008 Feb; 5(1):33-9. PubMed ID: 18318992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preferential Expression of Programmed Death Ligand 1 Protein in Tumor-Associated Macrophages and Its Potential Role in Immunotherapy for Hepatocellular Carcinoma.
    Park DJ; Sung PS; Lee GW; Cho S; Kim SM; Kang BY; Hur W; Yang H; Lee SK; Lee SH; Jung ES; Seo CH; Ahn J; Choi HJ; You YK; Jang JW; Bae SH; Choi JY; Yoon SK
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Costimulatory Molecules and Immune Checkpoints Are Differentially Expressed on Different Subsets of Dendritic Cells.
    Carenza C; Calcaterra F; Oriolo F; Di Vito C; Ubezio M; Della Porta MG; Mavilio D; Della Bella S
    Front Immunol; 2019; 10():1325. PubMed ID: 31244860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade.
    Peng Q; Qiu X; Zhang Z; Zhang S; Zhang Y; Liang Y; Guo J; Peng H; Chen M; Fu YX; Tang H
    Nat Commun; 2020 Sep; 11(1):4835. PubMed ID: 32973173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune Checkpoint Inhibition Followed by Tumor Infiltration of Dendritic Cells in Murine Neuro-2a Neuroblastoma.
    Inoue S; Horiuchi Y; Setoyama Y; Takeuchi Y; Beck Y; Murakami T; Odaka A
    J Surg Res; 2020 Sep; 253():201-213. PubMed ID: 32380346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD40-mediated immune cell activation enhances response to anti-PD-1 in murine intrahepatic cholangiocarcinoma.
    Diggs LP; Ruf B; Ma C; Heinrich B; Cui L; Zhang Q; McVey JC; Wabitsch S; Heinrich S; Rosato U; Lai W; Subramanyam V; Longerich T; Loosen SH; Luedde T; Neumann UP; Desar S; Kleiner D; Gores G; Wang XW; Greten TF
    J Hepatol; 2021 May; 74(5):1145-1154. PubMed ID: 33276030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.